These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26527820)

  • 41. Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
    Sriram D; Srichakravarthy N; Bal TR; Yogeeswari P
    Biomed Pharmacother; 2005 Sep; 59(8):452-5. PubMed ID: 16154314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy.
    Ross L; Johnson M; Graham N; Shaefer M; St Clair M
    J Hum Virol; 1999; 2(5):290-5. PubMed ID: 10551735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
    Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymers fight HIV: potent (pro)drugs identified through parallel automated synthesis.
    Zuwala K; Smith AA; Postma A; Guerrero-Sanchez C; Ruiz-Sanchis P; Melchjorsen J; Tolstrup M; Zelikin AN
    Adv Healthc Mater; 2015 Jan; 4(1):46-50. PubMed ID: 24811313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors.
    Blair WS; Isaacson J; Li X; Cao J; Peng Q; Kong GF; Patick AK
    Antiviral Res; 2005 Feb; 65(2):107-16. PubMed ID: 15708637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Chen X; Li Y; Ding S; Balzarini J; Pannecouque C; De Clercq E; Liu H; Liu X
    ChemMedChem; 2013 Jul; 8(7):1117-26. PubMed ID: 23650275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
    Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-HIV active petrosins from the marine sponge Petrosia similis.
    Venkateshwar Goud T; Srinivasa Reddy N; Raghavendra Swamy N; Siva Ram T; Venkateswarlu Y
    Biol Pharm Bull; 2003 Oct; 26(10):1498-501. PubMed ID: 14519963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual-reporter phenotypic assay for human immunodeficiency viruses.
    Kajiwara K; Kodama E; Sakagami Y; Naito T; Matsuoka M
    J Clin Microbiol; 2008 Feb; 46(2):792-5. PubMed ID: 18094135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of recombinant retroviruses to characterize the activity of antiretroviral compounds.
    Stair RK; Nelson CJ; Mellors JW
    J Virol; 1991 Nov; 65(11):6339-42. PubMed ID: 1920637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-1 indicator cell lines.
    Akrigg A; Wilkinson GW; Angliss S; Greenaway PJ
    AIDS; 1991 Feb; 5(2):153-8. PubMed ID: 1903260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measuring β-Galactosidase Activity in Gram-Positive Bacteria Using a Whole-Cell Assay with MUG as a Fluorescent Reporter.
    Chiu NHL; Watson AL
    Curr Protoc Toxicol; 2017 Nov; 74():4.44.1-4.44.8. PubMed ID: 29117437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensitivity to electrical stimulation of human immunodeficiency virus type 1 and MAGIC-5 cells.
    Kumagai E; Tominaga M; Harada S
    AMB Express; 2011 Aug; 1(1):23. PubMed ID: 21906386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies.
    Struble EB; Rawson JMO; Stantchev T; Scott D; Shapiro MA
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutting edge strategies for screening of novel anti-HIV drug candidates against HIV infection: A concise overview of cell based assays.
    Gaikwad SY; Phatak P; Mukherjee A
    Heliyon; 2023 May; 9(5):e16027. PubMed ID: 37215829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-HIV-1 activity determined by β-galactosidase activity in the multinuclear activation of an indicator assay is comparable with that by a conventional focus counting method.
    Miyamoto F; Kawaji K; Oishi S; Fujii N; Kaku M; Kodama EN
    Antivir Chem Chemother; 2015 Apr; 24(2):77-82. PubMed ID: 26527820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of three quantification methods for the TZM-bl pseudovirus assay for screening of anti-HIV-1 agents.
    Xing L; Wang S; Hu Q; Li J; Zeng Y
    J Virol Methods; 2016 Jul; 233():56-61. PubMed ID: 27016178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line.
    Pirounaki M; Heyden NA; Arens M; Ratner L
    J Virol Methods; 2000 Mar; 85(1-2):151-61. PubMed ID: 10716348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.
    Crespan E; Locatelli GA; Cancio R; Hübscher U; Spadari S; Maga G
    Antimicrob Agents Chemother; 2005 Jan; 49(1):342-9. PubMed ID: 15616314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.